EVALUATION OF A SERIES OF THYOSEMICARBAZONES AS INHIBITORS OF NEW DHELI METALLO-BETA-LACTAMASE-1
NDM; Beta Lactamases, Antimicrobial resistance, Thiosemicarbazones
In recent years, the global spread of bacterial resistance to β-lactam drugs has been observed, with carbapenem derivatives having an important role in the treatment of infections by multi-resistant bacteria. The expression of β-lactamase is mainly related to bacterial resistance, which requires the development of bacterial resistance blockers. Although combinations of β-lactam drugs and serine-β-lactamase inhibitors have been successful, such inhibitors are inactive against Metalo-β-lactamases especially, New Delhi Metalo-β-lactamase (NDM). So far, few compounds are active against NDM-producing bacteria and no specific inhibitors are available. A rational development strategy for NDM inhibitors begins with in vitro assays with the aim of identifying compounds that can act synergistically with β-lactam antibiotics. Thus, thiosemicarbazone derivatives were synthesized and investigated for their ability to reverse the NDM-resistant phenotype in Enterobacter cloacae. Phenotypic screening indicated that four beta-isatin-thiosemicarbazones showed Fractional Inhibitory Concentration (FIC) ≤ 250 µM in the presence of Meropenem (2 µg/mL) with compound 17, the most promising, (FIC = 31.25 µM) showing an effect synergistic (FIC index = 0.34). Docking and Molecular Dynamics studies on NDM-compound 17 complex suggested that 2,3-dihydro-1H-indol-2-one subunit of isatin-β interacts with catalytic zinc and performs hydrogen bonds with Asp-124 acting as a non-classical bioisostere of carboxylic acid. In addition, the tautomeric state of thiosemicarbazone with oxidized sulfur appears to act as a spacer instead of a zinc chelator and the aromatic portions are stabilized by pi-pi and pi-cation interactions with His189 and Lys221 residues. Our results addressed some structural characteristics of thiosemicarbazone in complex with NDM, and highlights its scaffold as promising alternatives to face bacterial resistance.